| Product |
CAS |
Molecular formula |
More |
| (5Z,9alpha,11alpha,13e,15s)-9,11,15-trihydroxy-n,n-dimethylprosta-5,13 |
68192-15-4 |
C22H39NO4 |
More |
| 2-(Palmitoylamino)ethanesulfonic acid |
83982-06-3 |
C18H37NO4S |
More |
| (5Z,9alpha,13e,15s)-9,15-dihydroxy-11-methylene-prosta-5,13-dien-1-oic |
100648-29-1 |
C21H34O4 |
More |
| (3Beta,20r)-cholest-5-en-3-yl (10z,12z)-9-hydroxy-10,12-octadecadienoa |
33783-76-5 |
C45H76O3 |
More |
| (11Alpha,13e,15s)-11,15-dihydroxy-15-methyl-9-oxo-prost-13-en-1-oic ac |
35700-26-6 |
C21H36O5 |
More |
| (11Alpha,13e,15s,19r)-11,15,19-trihydroxy-9-oxo-prost-13-en-1-oic acid |
64625-55-4 |
C20H34O6 |
More |
| Prostaglandin e1 ethyl ester |
35900-16-4 |
C22H38O5 |
More |
| 3-Carboxy-n,n,n-trimethyl-2-[(1-oxohexadecyl)oxy]-1-propanaminium chlo |
6865-14-1 |
C23H46ClNO4 |
More |
| (3S)-3-{[(benzyloxy)carbonyl]amino}-5-[(2,6-dichlorobenzoyl)oxy]-4-oxo |
153088-73-4 |
C20H17Cl2NO7 |
More |
| N-(5-isopropyl-1,3-thiazol-2-yl)-2-phenylacetamide |
267654-00-2 |
C14H16N2OS |
More |
| (2R,3s,4s)-tetrahydro-4,6-dihydroxy-2-[(1e,3s)-3-hydroxy-1-octen-1-yl] |
64626-32-0 |
C20H36O6 |
More |
| N-[(1r,2s)-2-hydroxy-1-methyl-2-phenylethyl]-tetradecanamide |
143492-38-0 |
C23H39NO2 |
More |
| (11Alpha,15s)-11,15-dihydroxy-9-oxo-prostan-1-oic acid |
19313-28-1 |
C20H36O5 |
More |
| 3-(6-Hydroxy-2,7,8-trimethyl-3,4-dihydro-2h-chromen-2-yl)propanoic aci |
178167-75-4 |
C15H20O4 |
More |
(5Z,8beta,9alpha,11alpha,13e,15r)-9,11,15-trihydroxy(3,3,4,4-2
| 211105-40-7 |
C20H30D4O5 |
More |
|
| Ethyl (8xi,13e)-15-hydroxy-9-oxoprosta-10,13-dien-1-oate |
93464-24-5 |
C22H36O4 |
More |
| N-phenyl-4-(2-quinolinylmethyl)-1-piperazinecarboxamide |
898235-65-9 |
C21H22N4O |
More |
| (5Z,8z,11z,14z)-17-hydroxy-5,8,11,14-icosatetraenoic acid |
183509-24-2 |
C20H32O3 |
More |
| (5Z,8z,11z,14z)-17-hydroxy-5,8,11,14-icosatetraenoic acid |
183509-25-3 |
C20H32O3 |
More |
| N-(3-nitrophenyl)decanamide |
72298-61-4 |
C16H24N2O3 |
More |
|
